Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study.
Zhu HH, Ma YF, Yu K, Ouyang GF, Luo WD, Pei RZ, Xu WQ, Hu HX, Mo SP, Xu XH, Lan JP, Shen JP, Shou LH, Qian SX, Feng WY, Zhao P, Jiang JH, Hu BL, Zhang J, Qian SY, Wu GQ, Wu WP, Qiu L, Li LJ, Lang XH, Chen S, Chen LL, Guo JB, Cao LH, Jiang HF, Xia YM, Le J, Zhao JZ, Huang J, Zhang YF, Lv YL, Hua JS, Hong YW, Zheng CP, Wang JX, Hu BF, Chen XH, Zhang LM, Tao S, Xie BS, Kuang YM, Luo WJ, Su P, Guo J, Wu X, Jiang W, Zhang HQ, Zhang Y, Chen CM, Xu XF, Guo Y, Tu JM, Hu S, Yan XY, Yao C, Lou YJ, Jin J; APL Cooperative Group of Zhejiang Province. Zhu HH, et al. Among authors: lan jp. Front Oncol. 2021 Nov 16;11:762653. doi: 10.3389/fonc.2021.762653. eCollection 2021. Front Oncol. 2021. PMID: 34868978 Free PMC article.
Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial.
Zhou X, Mei C, Zhang J, Lu Y, Lan J, Lin S, Zhang Y, Kuang Y, Ren Y, Ma L, Wei J, Ye L, Xu W, Li K, Lu C, Jin J, Tong H. Zhou X, et al. Hematol Oncol. 2020 Oct;38(4):531-540. doi: 10.1002/hon.2755. Epub 2020 Jun 24. Hematol Oncol. 2020. PMID: 32469434
Venetoclax plus hypomethylating agent for the salvage treatment of relapsing myeloid malignancies after hematopoietic stem cell transplantation: A multicenter retrospective study on behalf of the Zhejiang Cooperative Group for Blood and Marrow Transplantation.
Gao F, Gao Y, Luo Y, Yu J, Fu H, Lai X, Liu L, Ye B, Lan J, Song X, Lu Y, Chen L, Chen Y, Yu K, Huang H, Shi J, Zhao Y. Gao F, et al. Am J Hematol. 2022 Feb 1;97(2):E44-E47. doi: 10.1002/ajh.26405. Epub 2021 Nov 24. Am J Hematol. 2022. PMID: 34778993 Free article. No abstract available.
A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation.
Ma L, Liang B, Hu H, Yang W, Lin S, Cao L, Li K, Kuang Y, Shou L, Jin W, Lan J, Ye X, Le J, Lei H, Fu J, Lin Y, Jiang W, Zheng Z, Jiang S, Fu L, Su C, Yin X, Liu L, Qin J, Jin J, Qian S, Ouyang G, Tong H. Ma L, et al. Front Oncol. 2022 Jun 27;12:905490. doi: 10.3389/fonc.2022.905490. eCollection 2022. Front Oncol. 2022. PMID: 35832562 Free PMC article.
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective study.
Guan F, Yang L, Chen Y, Shi J, Song X, Lai X, Lu Y, Liu L, Ouyang G, Zhao Y, Yu J, Xu Y, Lan J, Fu H, Zhao Y, Qiu X, Zhu P, Cai Z, Huang H, Luo Y. Guan F, et al. Cancer. 2024 Feb 5. doi: 10.1002/cncr.35232. Online ahead of print. Cancer. 2024. PMID: 38315517
61 results